Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1366, 2002-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Coronary stenting "highly cost-effective" vs alteplase in MI
Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. :
Access to resources
Recommend
Coronary stenting "highly cost-effective" in MI vs alteplase
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. :
Alteplase cost-effective option for acute ischaemic stroke
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 333, 2001-01 ,pp. :
Alteplase reduces TFPI-1 activity in acute MI
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
Alteplase: a Safe and Cost‐Effective Alternative to Urokinase
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 2, 2002-06 ,pp. :